Genetic risk beyond APOE was linked to cognition, hippocampal volume, amyloid and tau across several ancestry groups.

Two rare mutations in the APOE gene ― APOE ε4 (R251G) and APOE ε3 (V236E) ― dramatically reduce the risk of developing Alzheimer's disease (AD), results of a large genetic association study show. APOE ...

Rather than sequestering Aβ to prevent its clearance from the brain, ApoE may indirectly block the peptide’s path to breakdown, according to results published April 25 in the Proceedings of the ...

When the results are analyzed in terms of relative risk, as done by Farrer and colleagues, [4] the APOE4 allele was found associated with an increased risk of AD, whereas the E2 allele appeared to ...

Despite the identification of the APOE gene as the strongest genetic link to late-onset Alzheimer's disease (AD) since 1993 and the subsequent advances in the understanding of AD pathogenesis, the ...

Apolipoprotein E4 (ApoE4), the Goliath of late-onset Alzheimer's disease genes (see AlzGene top results), is an enigma. Its protein clearly plays a role in AD and could be a therapeutic target, but ...

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid have found that one of the most potent genetic risk factors for Alzheimer's disease, apolipoprotein E4 (APOE4), ...

Alzheimer’s disease may be inherited more often than previously known, according to a new study that paints a clearer picture of a gene long known to be linked to the common form of dementia. The ...

Just days after news that an ultra-rare form of a cholesterol-related gene called APOE protected a Colombian woman from developing early-onset Alzheimer’s disease (as one of her other genes supposedly ...

Despite researchers' best efforts, no drug exists that can slow, halt or reverse the onslaught of Alzheimer's disease. A progressive and fatal neurodegenerative disorder, Alzheimer's has stolen the ...